Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

This study is currently recruiting participants.
Verified January 2014 by Mesoblast, Ltd.
Sponsor:
Information provided by (Responsible Party):
Mesoblast, Ltd.
ClinicalTrials.gov Identifier:
NCT01843387
First received: April 23, 2013
Last updated: January 7, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)